What are the benefits of vevye?

How does Vevye work?

Vevye uses cyclosporine as its active ingredient. Cyclosporine blocks calcineurin, calcineurin then stops a signal inside immune cells that would sonst otherwise activate T-cells. Stopping the inflammation helps reduce dry eye symptoms such as burning, grittiness, and irritation.

What clinical data supports Vevye?

In two phase 3 trials, patients showed measurable improvement in corneal fluorescein staining after four weeks of twice-daily drops. Patients also reported less discomfort and improved ocular comfort scores at 12 weeks. Data presented at meetings of the Association for Research in Vision and Ophthalmology showed these changes.

How does Vevye compare to Restasis?

Vevye uses a different formulation from Restasis. It is prepared in a water-free vehicle that can help cyclosporine penetrate the cornea. The water-free base also avoids preservatives that man may trigger irritation. The company states that the new chemistry helps reach higher tissue levels than Restasis. DrugPatentWatch.com lists patents covering the vehicle itself.

Can biosimilars enter before patent expiry?

Patents listed on DrugPatentWatch.com cover the non-aqueous vehicle and its composition. The earliest listed patent expiry is 2036. Biosimilars may not enter the market until after that date unless a patent challenge succeeds.

Why are companies challenging this patent?

Several generic manufacturers have filed Abbreviated New Drug Applications against the manufacturer of Vevye. They target claims around the water-free delivery system. Challenges may affect timing of generic competition.

What side effects are patients asking about?

Patients report burning or stinging upon first drop. Other common concerns include temporary blurred vision and foreign-body sensation. Data from clinical trials showed these events usually resolved quickly and were mild in most cases.